Biolase (BIOL) Reports Q4 EPS of ($0.03)

Biolase (NASDAQ: BIOL) reported Q4 EPS of ($0.03). Revenue for the quarter came in at $12.4 million versus the consensus estimate of $11.97 million.

For earnings history and earnings-related data on Biolase (BIOL) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• SeaStar Medical (ICU) Misses Q1 EPS by 4c
• ArriVent BioPharma, Inc. (AVBP) Misses Q2 EPS by 13c